UBS Maintains Neutral on UiPath, Lowers Price Target to $12

Benzinga Newsdesk www.benzinga.com Negative 57.5%

Neg 57.5% Neu 0% Pos 0%

UBS analyst Radi Sultan maintains UiPath (NYSE:PATH) with a Neutral and lowers the price target from $13 to $12.

Comments

No comments yet. Be the first!